Table 1.
Study participants for mDC isolations.
| HIV status | Age (years) | Gender | Treatment | Estimated time since HIV± (years) | Time since ART (years) | Viral RNA copies/ml | CD4 T cells/μl |
|---|---|---|---|---|---|---|---|
| HIVp1 | 28 | M | ART | 2 | 2 | <50 | 447 |
| HIVp2 | 52 | M | ART | 15 | 13 | 392 | 654 |
| HIVp3 | 51 | F | TN | 12 | NA | 5,970 | 641 |
| HIVp4 | 41 | M | ART | 12 | 6 | <50 | 619 |
| HIVp5 | 21 | M | TN | 1 | NA | 304, 742 | 513 |
| HIVp6 | 52 | M | TN | 20 | NA | 19,998 | 430 |
| HIVn1, 2, 3, 4 | § | § | NA | NA | NA | NA | * |
The cohort included antiretroviral therapy (ART)-treated and treatment-naïve (TN) (in bold) people living with HIV (PLWH) as well as HIV-uninfected persons. HIVp, HIV positive; HIVn, HIV negative; NA, not applicable; §, unavailable; *within normal ranges for CD4 T cells.